Search Results
Results found for "Howard Hughes"
- 📰 GPCR Weekly News, June 19 to 25, 2023
Structural and Molecular Insights into GPCR Function Structure-Activity Relationship Study of the High-Affinity
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
Prior to this report we did not know how different serotonin receptor subtypes which share high sequence
- 📰 GPCR Weekly News, March 4 to 10, 2024
Cone Pigment Activation Molecular dynamics-based identification of binding pathways and two distinct high-affinity
- Understanding Enzyme Inhibition In GPCR Discovery Programs
GPCR Premium: Sneak Peek Here’s a curated, high-signal preview of what Premium Members get this week—no
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
A high-affinity ligand often has higher efficacy, but the relationship is not linear.
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
GPCR Premium: Sneak Peek Here’s a fast, high-level preview of what Premium Members are unpacking this
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
here ➤ Discovery on Target 2025 – GPCR Speaker Spotlight DOT 2025 (Sept 22–25, Boston) is set to be a high-signal
- HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G 1/S cycle
S-transferase; HCC: hepatocellular carcinoma; HBV: hepatitis B virus; HBx: hepatitis B virus X protein; HMGB1: high
- Quantifying Receptor Selectivity in Modern Drug Discovery
If the assay threshold is too high, real pharmacology becomes invisible.
- The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of ...
dependent signalling correlated with reduced mobilisation of lytically-infected DC to draining lymph node high
- Exploring the Breakthroughs in GPCR Research
Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia Methods & Updates in GPCR Research High-throughput
- 📰 GPCR Weekly News, June 24 to 30, 2024
site-selective activation of mTOR GPCR Binders, Drugs, and more Molecular glues as potential GPCR therapeutics A high-affinity
- Why Kinetics Matter More Than Kd in GPCR Drug Discovery
translational success: How post-COVID insights and unconventional decision-making shaped Serafini’s high-impact
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
Insomnia Patient in its Phase 3 Clinical Trial of Daridorexant in South Korea Septerna Touches New High
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
Recently, several high-throughput screening (HTS) assays for ERK activation have been developed, each
- 📰 GPCR Weekly News, November 6 to November 12, 2023
lipid second messenger signaling Methods & Updates in GPCR Research An image-based abplex method for high-throughput
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
sets the activity pattern in the C. elegans egg-laying circuit Methods & Updates in GPCR Research High-throughput
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Should Enroll Now: Cost-effective & Distinctive Educational Experience Affordable courses that maintain high-quality
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
The Tissue Penetration Trap Here’s a paradox: high-affinity, slow-offset compounds can undermine their
- 📰 GPCR Weekly News, September 18 to 24, 2023
A huge thank you to our amazing speakers and everyone who showed up.
- 📰 GPCR Weekly News, September 11 to 17, 2023
receptor sensor GPCRs in Oncology and Immunology Phase 1/2 study of sorafenib added to cladribine, high-dose
- 📰 GPCR Weekly News, March 11 to 17, 2024
Prostaglandin E2 EP3 Receptor Has Disparate Effects on Islet Insulin Secretion and Content in β-cells in a High
- From Snapshots to Predictions: Why Mechanism of Action Matters
A model answered: yes—provided CD4 concentrations stayed low and gp120 concentrations high.
- 📰 GPCR Weekly News, May 8 to 14, 2023
Drugs, and more In-depth molecular profiling of an intronic GNAO1 mutant as the basis for personalized high-throughput
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
Amplify your research: Contribute to a high-impact collection of work that will shape the future of
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Introduction Life scientists dedicate enormous resources towards meticulously understanding and implementing prime targets, it is our duty to routinely clean our lens of misleading artefacts and focus our efforts towards
- 📰 GPCR Weekly News, June 26 to July 2, 2023
High expression of GPR50 promotes the proliferation, migration and autophagy of hepatocellular carcinoma
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
receptor 4 (PAR4) in mouse models of acute and chronic kidney injury GPCR Binders, Drugs, and more High-throughput
- 📰 GPCR Weekly News, February 27 to March 5, 2023
Establishment of a CaCC-based Cell Model and Method for High-throughput Screening of M3 Receptor Drugs
- 📰 GPCR Weekly News, November 20 to 26, 2023
Oncology and Immunology RGS5 maintaining vascular homeostasis is altered by the tumor microenvironment High















